Literature DB >> 11475006

On the role of peripheral macrophages during active experimental allergic encephalomyelitis (EAE).

H Imrich1, K Harzer.   

Abstract

Experimental allergic encephalitis (EAE) is an experimental autoimmune inflammatory condition of the central nervous system (CNS) that serves as a disease model for multiple sclerosis (MS). The primary effector mechanisms of the immune system leading to tissue destruction during EAE remain still controversial. T-cells, microglia, and macrophages infiltrating the brain parenchyma are suggested to be involved. To clarify the role of these cells during disease Lewis rats were immunised with different immunisation protocols: Immunisation with myelin basic protein (MBP) in complete Freunds adjuvant (CFA) containing high dose of mycobacterial components induced severe disease, whereas immunisation with low dose of mycobacterial components induced only mild disease. Severely and mildly diseased animals were analysed with respect to infiltration of T-cells, macrophages and upregulation of MHC class II molecules on microglia in the brain. All immunised rats showed high T-cell infiltration accompanied by microglia activation. The degree of disease and the infiltration of macrophages varied with dose of adjuvant. Lowering the dose of adjuvant prevented the development of disease but also the influx of peripheral macrophages into the brain without affecting the peripheral T-cell response to the autoantigen. Thus, appearance of (autoreactive) T-cells in the brain and microglia activation were probably not sufficient for development of disease. It can be concluded that peripheral macrophages play an essential or even key role in the pathogenesis of active EAE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11475006      PMCID: PMC7087617          DOI: 10.1007/s007020170060

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  6 in total

1.  Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice.

Authors:  William V Nikolic; Huayan Hou; Terrence Town; Yuyan Zhu; Brian Giunta; Cyndy D Sanberg; Jin Zeng; Deyan Luo; Jared Ehrhart; Takashi Mori; Paul R Sanberg; Jun Tan
Journal:  Stem Cells Dev       Date:  2008-06       Impact factor: 3.272

2.  Multiple low-dose infusions of human umbilical cord blood cells improve cognitive impairments and reduce amyloid-β-associated neuropathology in Alzheimer mice.

Authors:  Donna Darlington; Juan Deng; Brian Giunta; Huayan Hou; Cyndy D Sanberg; Nicole Kuzmin-Nichols; Hua-Dong Zhou; Takashi Mori; Jared Ehrhart; Paul R Sanberg; Jun Tan
Journal:  Stem Cells Dev       Date:  2012-09-05       Impact factor: 3.272

3.  Temporal pattern of plasma membrane calcium ATPase 2 expression in the spinal cord correlates with the course of clinical symptoms in two rodent models of autoimmune encephalomyelitis.

Authors:  Arnaud Nicot; Michael Kurnellas; Stella Elkabes
Journal:  Eur J Neurosci       Date:  2005-05       Impact factor: 3.386

4.  Metallic gold slows disease progression, reduces cell death and induces astrogliosis while simultaneously increasing stem cell responses in an EAE rat model of multiple sclerosis.

Authors:  Dan Sonne Pedersen; Pil Møntegaard Fredericia; Mie Ostergaard Pedersen; Meredin Stoltenberg; Milena Penkowa; Gorm Danscher; Jørgen Rungby; Agnete Larsen
Journal:  Histochem Cell Biol       Date:  2012-07-22       Impact factor: 4.304

5.  Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis.

Authors:  Elimor Brand-Schieber; Peter Werner; Dumitru A Iacobas; Sanda Iacobas; Michelle Beelitz; Stuart L Lowery; David C Spray; Eliana Scemes
Journal:  J Neurosci Res       Date:  2005-06-15       Impact factor: 4.164

6.  Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β.

Authors:  Anne Skøttrup Mørkholt; Kenneth Kastaniegaard; Michael Sloth Trabjerg; Gopana Gopalasingam; Wanda Niganze; Agnete Larsen; Allan Stensballe; Søren Nielsen; John Dirk Nieland
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.